Quick Answer
Moderna, Inc. reported Diluted EPS of $7.26 per share (loss) for fiscal year 2025.
Moderna, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$7.26 | +21.8% |
| 2024 | -$9.28 | +24.7% |
| 2023 | -$12.33 | -161.3% |
| 2022 | $20.12 | -28.9% |
| 2021 | $28.29 | +1543.4% |
| 2020 | -$1.96 | -26.5% |
| 2019 | -$1.55 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.51 | -1800.0% | +76.1% |
| June 30, 2025 | -$2.13 | +36.0% | +15.5% |
| March 31, 2025 | -$2.52 | +17.9% | -8500.0% |
| September 30, 2024 | $0.03 | +100.3% | +100.9% |
| June 30, 2024 | -$3.33 | +8.0% | -8.5% |
| March 31, 2024 | -$3.07 | -1715.8% | +67.8% |
| September 30, 2023 | -$9.53 | -476.7% | -163.3% |
| June 30, 2023 | -$3.62 | -169.1% | -2005.3% |
- Moderna, Inc. showed an increase of +21.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Moderna, Inc.’s diluted eps has declined by 368.4% (from $1.55 per share (loss) to $7.26 per share (loss)).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: